11.04.2021, 2318 Zeichen
Valneva: Valneva, an Austrian/French specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced positive data for Part A of the Phase 1/2 clinical trial of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. Based on this data, the Company plans to commence a Phase 3 clinical trial by the end of April 2021, subject to regulatory approval. In study VLA2001-201, three dose levels of VLA2001 (low, medium, high), based on a schedule of two doses with vaccinations three weeks apart, were evaluated in 153 healthy adults aged 18 to 55 years.
Valneva: weekly performance:
S&T: IT company S&T concluded a purchase agreement for the acquisition of 100% of the shares in Axino Solutions GmbH, based in Aachen, Germany. Axino, founded on 1 January 2016, achieved revenues of Euro 7 mn in 2020 with just under 50 employees and offers its services in central Germany as a system house with its own IoT products. Due to the high product development costs in the IoT sector and the adverse effects of the COVID-19-Pandemic, insolvency proceedings were initiated in January 2021, which will now be terminated following the entry of the S&T Group. The fixed purchase price for 100% of Axino amounts to Euro 200.000. Hannes Niederhauser, CEO of S&T AG: "The acquisition of Axino is a good example of our new "M&A Ligth Process". It allows us to react quickly and efficiently to acquisition opportunities. Especially in the current COVID-19-Crisis, this is proving to be advantageous. We will achieve slight profits with Axino as early as 2021 and, with 50 experienced technicians, we are strengthening our presence in Germany. I am confident that we will succeed in making more acquisitions of this kind in the near future."
S&T: weekly performance:
Strabag: Strabag Property and Facility Services GmbH acquired the business operations of BAM Facility Services GmbH (BAM FS). The company, based in Hallbergmoos near Munich, was founded in 2007 and achieved sales of around Euro 4 mn in the 2020 financial year. The parties have agreed not to disclose the purchase price.
Strabag: weekly performance:
(From the 21st Austria weekly https://www.boerse-social.com/21staustria (06/04/2021)
Wiener Börse Party #800: Uniqa und Wienerberger mit guten Aussagen, Kapitalmarktstimme bei SDG Awards, Trauer um Claus Raidl
Aktien auf dem Radar:Porr, UBM, Zumtobel, Immofinanz, Addiko Bank, CA Immo, Erste Group, Bawag, Rosgix, Pierer Mobility, AT&S, Verbund, Kapsch TrafficCom, Cleen Energy, Gurktaler AG Stamm, Kostad, Marinomed Biotech, Wolford, Warimpex, Agrana, Amag, EVN, Flughafen Wien, OMV, Palfinger, Österreichische Post, Telekom Austria, Uniqa, VIG.
Croma
Croma Pharma® ist ein österreichisches Familienunternehmen mit Sitz in Leobendorf. Das Unternehmen ist auf die industrielle Fertigung von Hyaluronsäure-Spritzen spezialisiert und zählt in diesem Bereich europaweit zu den führenden Experten. Das Unternehmen setzt mit eigenen Marken auf die Wachstumssparte der minimalinvasiven ästhetischen Medizin.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner
Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab.
Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.
Newsletter abonnieren
Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)
per Newsletter erhalten